Who makes [90Y]Y-PentixaTher?

[90Y]Y-PentixaTher is developed by Pentixapharm AG.

What development phase is [90Y]Y-PentixaTher in?

[90Y]Y-PentixaTher is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[90Y]Y-PentixaTher

Pentixapharm AG · Phase 1 active Small molecule

At a glance

Generic name	[90Y]Y-PentixaTher
Also known as	[90Y]Y-PTT
Sponsor	Pentixapharm AG
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[90Y]Y-PentixaTher CI brief — competitive landscape report
[90Y]Y-PentixaTher updates RSS · CI watch RSS
Pentixapharm AG portfolio CI